TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
ARGX

argenx NV

Healthcare · Biotechnology

856.90$ -2.2% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ARGX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-493.3% -362.8%
+33.5% +63.9% +48.6% +8.1% +330.0% +61.5% +49.8% +1,678.5% +6.7% -84.3% +60.3%
+114.3% +20.7% +70.9% +328.6% +101.6% +119.1% +85.0% -12.5% +48.4% +0.9% +5.5%
+241.3% +30.8% +236.4% -64.1% +443.8% +932.1% -28.3% -13.5%
-115.4% -172.6% +2,939.5% -109.2%
+35.6% +197.0% -53.5% +85.7% +5,876.3% -89.0% +2,263.0% -14.5% -57.8% +55.9% -90.9%
-104.6% +22,826.2% -36.7% +577.4% -200.7% +32.9% -332.8%
+114,590,064.2% -91.8% +20,998,005.0% -100.0% +122.0% +80.2%
+0.0% +0.0% +0.0% +64.8% +72.9% +8.0% -8.7% +100.9% -46.2%
-99.4% +17,935.0% +680.7% -23.6% +162.2% +13.5% +34.6% -24.8% +58.4% -79.1% -16.5%
-68.3% +1,469.1% +111.8% -14.8% -51.2% +1,576.8% -86.0% -553.0% -144.0%
-532.2% -484.8%

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?